MGlu3 receptor and astrocytes: Partners in neuroprotection

Neuropharmacology

Volumn 66, Issue , 2013, Pages 1-11

  Durand, Daniela ^a   Carniglia, Lila ^a   Caruso, Carla ^a   Lasaga, Mercedes ^a  

^a UNIVERSIDAD DE BUENOS AIRES   (Argentina)

Author keywords

Astrocytes; mGlu3 receptor; Physiopathology

Indexed keywords

2 (CARBOXYCYCLOPROPYL)GLYCINE; 4 AMINO 2 OXABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID; 4 AMINO 2 THIABICYCLO[3.1.0]HEXANE 4,6 DICARBOXYLIC ACID 2,2 DIOXIDE; AMYLOID BETA PROTEIN; EGLUMETAD; METABOTROPIC RECEPTOR 2; METABOTROPIC RECEPTOR 2 AGONIST; METABOTROPIC RECEPTOR 3; METABOTROPIC RECEPTOR 3 AGONIST; METABOTROPIC RECEPTOR AGONIST; POMAGLUMETAD METHIONIL; TALAGLUMETAD; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

ALZHEIMER DISEASE; ASTROCYTE; AUTOCRINE EFFECT; CELL SURVIVAL; CHRONIC PAIN; DEPRESSION; DRUG DEPENDENCE; DRUG DETERMINATION; EPILEPSY; GENERALIZED ANXIETY DISORDER; GLIA CELL; HUMAN; NERVE CELL DIFFERENTIATION; NERVE FUNCTION; NERVE GROWTH; NEUROPATHOLOGY; NEUROPROTECTION; NEUROPSYCHOLOGY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN TARGETING; REVIEW; SCHIZOPHRENIA;

ANIMALS; ASTROCYTES; EXCITATORY AMINO ACID AGONISTS; HUMANS; LIGANDS; MENTAL DISORDERS; MODELS, NEUROLOGICAL; MOLECULAR TARGETED THERAPY; NEURODEGENERATIVE DISEASES; NEUROPROTECTIVE AGENTS; RECEPTORS, METABOTROPIC GLUTAMATE;

EID: 84872164218     PISSN: 00283908     EISSN: 18737064     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2012.04.009     Document Type: Review

References (167)

1. N.J. Abbott Astrocyte-endothelial interactions and blood-brain barrier permeability J. Anat. 200 2002 629 638
2. N.J. Abbott Inflammatory mediators and modulation of blood-brain barrier permeability Cell Mol. Neurobiol. 20 2000 131 147
3. P.J. Albrecht, U. Sonnewald, H.S. Waagepetersen, and A. Schousboe Glutamine in the central nervous system: function and dysfunction Front. Biosci. 12 2007 332 343
4. P.J. Albrecht, J.P. Dahl, O.K. Stoltzfus, R. Levenson, and S.W. Levison Ciliary neurotrophic factor activates spinal cord astrocytes, stimulating their production and release of FGF-2, to increase motor neuron survival Exp. Neurol. 173 2002 46 62
5. M. Amiry-Moghaddam, and O.P. Ottersen The molecular basis of water transport in the brain Nat. Rev. Neurosci. 4 2003 991 1001
6. C. Anderson, and R. Swanson Astrocyte glutamate transport: review of properties, regulation, and physiological functions Glia 32 2000 1 14
7. R. Anwyl Metabotropic glutamate receptors: electrophysiological properties and role in plasticity Brain Res. Rev. 29 1999 83 120
8. A. Araque, V. Parpura, R.P. Sanzgiri, and P.G. Haydon Tripartite synapses: glia, the unacknowledged partner Trends Neurosci. 22 1999 208 215
9. E. Aronica, J.A. Gorter, A.J. Rozemuller, B. Yancaya, and D. Troost Activation of metabotropic glutamate receptor 3 enhances interleukin (IL)-1beta-stimulated release of IL-6 in cultured human astrocytes Neuroscience 130 2005 927 933
10. E. Aronica, J.A. Gorter, H. Ijlst-Keizers, A.J. Rozemuller, B. Yankaya, Leenstra, and D. Troost Expression and functional role of mGluR3 and mGluR5 in human astrocytes and glioma cells: opposite regulation of glutamate transporter proteins Eur. J. Neurosci. 17 2003 2106 2118
11. E. Aronica, E.A. Van-Vliet, O.A. Mayboroda, D. Troost, F.H. Da-Silva, and J.A. Goterm Upregulation of metabotropic glutamate receptor subtype mGluR3 and mGluR5 in reactive astrocytes in a rat model of mesial temporal lobe epilepsy Eur. J. Neurosci. 12 2000 2333 2344
12. P. Bäckström, and P. Hyytiä Suppression of alcohol self-Administration and cue-induced reinstatement of alcohol seeking by the mGlu2/3 receptor agonist LY379268 and the mGlu8 receptor agonist (S)-3,4-DCPG Eur. J. Pharmacol. 528 2005 110 118
13. D.A. Baker, Z.-X. Xi, H. Shen, C.J. Swanson, and P.W. Kalivas The origin and neuronal function of in vivo nonsynaptic glutamate J. Neurosci. 22 2002 9134 9141
14. R. Balázs, S. Miller, C. Romano, A. de Vries, Y. Chun, and C.W. Cotman Metabotropic glutamate receptor mGluR5 in astrocytes: pharmacological properties and agonist regulation J. Neurochem. 69 1997 151 163
15. M.A. Baptista, R. Martin-Fardon, and F. Weiss Preferential effects of the metabotropic glutamate 2/3 receptor agonist LY379268 on conditioned reinstatement versus primary reinforcement: comparison between cocaine and a potent conventional reinforcer J. Neurosci. 24 2004 4723 4727
16. G. Battaglia, C.L. Busceti, F. Pontarelli, F. Biagioni, F. Fornai, A. Paparelli, V. Bruno, S. Ruggieri, and F. Nicoletti Protective role of group-II metabotropic glutamate receptors against nigro-striatal degeneration induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice Neuropharmacology 45 2003 155 166
17. E.E. Benarroch Neuron-Astrocyte interactions: partnership for normal function and disease in the central nervous system Mayo Clin. Proc. 80 2005 1326 1338
18. A. Berent-Spillson, and J.W. Russell Metabotropic glutamate receptor 3 protects neurons from glucose-induced oxidative injury by increasing intracellular glutathione concentration J. Neurochem. 101 2007 342 354
19. A. Berent-Spillson, A.M. Robinson, D. Golovoy, B. Slusher, C. Rojas, and J.W. Russell Protection against glucose-induced neuronal death by NAAG and GCP II inhibition is regulated by mGluR3 J. Neurochem. 89 2004 90 99
20. J.V. Berger, A.O. Dumont, M.C. Focant, M. Vergouts, A. Sternotte, A.G. Calas, S. Goursaud, and E. Hermans Opposite regulation of metabotropic glutamate receptor 3 and metabotropic glutamate receptor 5 by inflammatory stimuli in cultured microglia and astrocytes Neuroscience 205 2012 29 38
21. V.M. Blanco, J.E. Stern, and J.A. Filosa Tone-dependent vascular responses to astrocyte-derived signals Am. J. Physiol. Heart Circ. Physiol. 294 2008 2855 2863
22. A. Bond, N. Ragummorthy, J.A. Monn, C.A. Hicks, M.A. Ward, D. Lodge, and M.F. O'Neill LY379268, a potent and selective group II metabotropic glutamate receptor agonist, is neuroprotective in gerbil global, but not focal, cerebral ischaemia Neurosci. Lett. 273 1999 191 194
23. J.M. Bossert, R.F. Busch, and S.M. Gray The novel mGluR2/3 agonist LY379268 attenuates cue-induced reinstatement of heroin seeking Neuroreport 16 2005 1013 1016
24. V. Bruno, G. Battaglia, G. Casabona, A. Copani, F. Caciagli, and F. Nicoletti Neuroprotection by glial metabotropic glutamate receptor is mediated by transforming growth factor-beta J. Neurosci. 18 1998 9594 9600
25. J. Busciglio, D.H. Gabzuda, P. Matsudaira, and B.A. Yanker Generation of β-Amyloid in the secretory pathway in neuronal and nonneuronal cells Proc. Natl. Acad. Sci. U.S.A. 90 1993 2092 2096
26. K.R. Byrnes, D.J. Loane, and A.I. Faden Metabotropic glutamate receptors as targets for multipotential treatment of neurological disorders Neurotherapeutics 6 2009 94 107
27. Z. Cai, F. Xiao, J.D. Fratkin, and E.G. Rhodes Protection of neonatal rat brain from hypoxic-ischemic injury by LY379268, a group II metabotropic glutamate receptor agonist Neuroreport 10 1999 3927 3931
28. F. Caraci, G. Molinaro, G. Battaglia, M.L. Giuffrida, B. Riozzi, A. Traficante, V. Bruno, M. Cannella, S. Merlo, X. Wang, B.A. Heinz, E.S. Nisenbaum, T.C. Britton, F. Drago, M.A. Sortino, A. Copani, and F. Nicoletti Targeting group-II metabotropic glutamate receptors for the treatment of psychosis associated with Alzheimer's disease: selective activation of mGlu2 receptors amplifies β-Amyloid toxicity in cultured neurons whereas dual activation of mGlu2 and mGlu3 receptors is neuroprotective Mol. Pharmacol. 79 2011 618 626
29. F. Caraci, G. Battaglia, V. Bruno, P. Bosco, V. Carbonaro, M.L. Giuffrida, F. Drago, M.A. Sortino, F. Nicoletti, and A. Copani TGF-beta1 pathway as a new target for neuroprotection in Alzheimer's disease CNS Neurosci. Ther. 17 2011 237 249
30. B.M. Carlson Human Embryology and Developmental Biology third ed. 2004 Mosby Saint Louis
31. J. Cartmell, and D. Schoepp Regulation of neurotransmitter release by metabotropic glutamate receptors J. Neurochem. 75 2000 889 907
32. L. Ceolin, S. Kantamneni, G.R. Barker, L. Hanna, L. Murray, E.C. Warburton, E.S. Robinson, J.A. Monn, S.M. Fitzjohn, G.L. Collingridge, Z.A. Bortolotto, and D. Lodge Study of novel selective mGlu2 agonist in the temporo-Ammonic input to CA1 neurons reveals reduced mGlu2 receptor expression in a Wistar substrain with an anxiety-like phenotype J. Neurosci. 31 2011 6721 6731
33. S. Chaki Group II metabotropic glutamate receptor agonists as a potential drug for schizophrenia Eur. J. Pharmacol. 639 2010 59 66
34. S. Chaki, S. Yoshida, and S. Okuyama Targeting metabotropic glutamate receptors to develop novel antipsychotics Jpn. J. Psychopharmacol. 30 2010 207 213
35. F.A. Chaudhry, K.P. Lehre, M. van Lookeren Campagne, O.P. Ottersen, N.C. Danbolt, and J. Storm-Mathisen Glutamate transporters in glial plasma membranes: highly differentiated localizations revealed by quantitative ultrastructural immunocytochemistry Neuron 15 1995 711 720
36. Q. Chen, G. He, Q. Chen, S. Wu, Y. Xu, G. Feng, Y. Li, L. Wang, and L. He A case-control study of the relationship between the metabotropic glutamate receptor 3 gene and schizophrenia in the Chinese population Schizophr. Res. 73 2005 21 26
37. S. Chiechio, A. Caricasole, E. Barletta, M. Storto, M.V. Catania, A. Copani, M. Vertechi, R. Nicolai, M. Calvani, M. Melchiorri, and F. Nicoletti l-Acetylcarnitine induces analgesia by selectively upregulating mGlu2 metabotropic glutamate receptors Mol. Pharmacol. 61 2002 989 996
38. M. Chopra, Y. Yao, T.J. Blake, D.R. Hampson, and E.C. Johnson The neuroactive peptide N-Acetylaspartylglutamate (NAAG) is not an agonist at the mGluR3 subtype of metabotropic glutamate receptor J. Pharmacol. Exp. Ther. 330 2009 212 219
39. 1 adenosine and mGluR3 metabotropic glutamate receptor activation against apoptosis by oxygen/glucose deprivation in cultured astrocytes Mol. Pharmacol. 71 2007 1369 1380
40. R. Ciccarelli, P. Di Iorio, V. Bruno, G. Battaglia, I. D'Alimonte, M. D'Onofrio, F. Nicoletti, and F. Caciagli Activation of A1 adenosine or mGluR3 metabotropic glutamate receptors enhances the release of nerve growth factor and S-100beta protein from cultured astrocytes Glia 27 1999 275 281
41. D.F. Condorelli, P. Dell'Albani, M. Corsaro, R. Giuffrida, A. Caruso, A. Trovato Salinaro, F. Spinella, F. Nicoletti, V. Albanese, and A.M. Giuffrida Stella Metabotropic glutamate receptor expression in cultured rat astrocytes and human gliomas Neurochem. Res. 22 1997 1127 1133
42. P.J. Conn, and C.K. Jones Promise of mGluR2/3 activators in psychiatry Neuropsychopharmacology 34 2009 248 249
43. A.H. Cornell-Bell, S.M. Finkbeiner, M.S. Cooper, and S.J. Smith Glutamate induces calcium waves in cultured astrocytes: long range glial signaling Science 247 1990 470 473
44. C. Corti, G. Battaglia, G. Molinaro, B. Riozzi, A. Pittaluga, M. Corsi, M. Mugnaini, F. Nicoletti, and V. Bruno The use of knock-out mice unravels distinct roles for mGlu2 and mGlu3 metabotropic glutamate receptors in mechanisms of neurodegeneration/neuroprotection J. Neurosci. 27 2007 8297 8308
45. M. D'Onofrio, L. Cuomo, G. Battaglia, R.T. Ngomba, M. Storto, A.E. Kingston, F. Orzi, A. De Blasi, P. Di Iorio, F. Nicoletti, and V. Bruno Neuroprotection mediated by glial group-II metabotropic glutamate receptors requires the activation of the MAP kinase and the phosphatidylinositol-3-kinase pathways J. Neurochem. 78 2001 435 445
46. N.C. Danbolt Glutamate uptake Prog. Neurobiol. 65 2001 1 105
47. S. Dolan, J.G. Kelly, A.M. Monteiro, and A.M. Nolan Up-regulation of metabotropic glutamate receptor subtypes 3 and 5 in spinal cord in a clinical model of persistent inflammation and hyperalgesia Pain 106 2003 501 512
48. R. Dringen, R. Gebhardt, and B. Hamprecht Glycogen in astrocytes: possible function as lactate supply for neighboring cells Brain Res. 623 1993 208 214
49. E. Dunayevich, J. Erickson, L. Levine, R. Landbloom, D.D. Schoepp, and G.D. Tollefson Efficacy and tolerability of an mGlu2/3 agonist in the treatment of generalized anxiety disorder Neuropsychopharmacology 33 2008 1603 1610
50. D. Durand, L. Carniglia, C. Caruso, and M. Lasaga Metabotropic glutamate receptors in peripheral tissues: implications for toxicology V. Kalinin, Anxiety Disorders 2011 Intech Open Access Publisher Rijeka, Croatia 97 120
51. D. Durand, L. Carniglia, C. Caruso, and M. Lasaga Reduced cAMP, Akt activation and p65-c-Rel Dimerization: mechanisms involved in the protective effects of mGluR3 agonists in cultured astrocytes PLoS ONE 6 7 2011 e22235 10.1371/journal.pone.0022235
52. D. Durand, C. Caruso, L. Carniglia, and M. Lasaga Metabotropic glutamate receptor 3 activation prevents nitric oxide-induced death in cultured rat astrocytes J. Neurochem. 112 2010 420 433
53. S. Efthimiopoulos, S. Punj, V. Manolopoulos, M. Pangalos, G.P. Wang, L.M. Refolo, and N.K. Robakis Intracellular cyclic AMP inhibits constitutive and phorbol ester-stimulated secretory cleavage of amyloid precursor protein J. Neurochem. 67 1996 872 875
54. M.F. Egan, R.E. Straub, T.E. Goldberg, I. Yakub, J.H. Callicott, A.R. Hariri, V.S. Mattay, A. Bertolino, T.M. Hyde, C. Shannon-Weickert, M. Akil, J. Crook, R.K. Vakkalanka, R. Balkissoon, R.A. Gibbs, J.E. Kleinman, and D.R. Weinberger Variation in GRM3 affects cognition, prefrontal glutamate, and risk for shizophrenia Proc. Natl. Acad. Sci. U.S.A. 101 2004 12604 12609
55. D.L. Eng, Y.L. Lee, and P.G. Lal Expression of glutamate uptake transporters after dibutyryl cyclic AMP differentiation and traumatic injury in cultured astrocytes Brain Res. 778 1997 215 221
56. M.J. Fell, K.A. Svensson, B.G. Johnson, and D.D. Schoepp Evidence for the role of metabotropic glutamate (mGlu)2 not mGlu3 receptors in the preclinical antipsychotic pharmacology of the mGlu2/3 receptor agonist (-)-(1R,4S,5S,6S)-4- Amino-2-sulfonylbicyclo[3.1.0]hexane-4,6-dicarboxylic acid (LY404039) J. Pharmacol. Exp. Ther. 326 2008 209 217
57. F. Ferraguti, C. Corti, E. Valerio, S. Mion, and J. Xuereb Activated astrocytes in areas of kainate-induced neuronal injury upregulate the expression of the metabotropic glutamate receptors 2/3 and 5 Exp. Brain Res. 137 2001 1 11
58. M.E. Fraley Positive allosteric modulators of the metabotropic glutamate receptor 2 for the treatment of schizophrenia Exp. Opin. Ther. Pat. 19 2009 1259 1275
59. A.C. Fricker, M.H. Mok, R. de la Flor, A.J. Shah, M. Woolley, L.A. Dawson, and J.N. Kew Effects of N-Acetylaspartylglutamate (NAAG) at group II mGluRs and NMDAR Neuropharmacology 56 2009 1060 1067
60. Y. Fujii, H. Shibata, R. Kikuta, C. Makino, A. Tani, N. Hirata, A. Shibata, H. Ninomiya, N. Tashiro, and Y. Fukumaki Possitive associations of polymorphisms in the metabotropic glutamate receptor type 3 gene (GRM3) with schizophrenia Psychiatr. Genet. 13 2003 71 76
61. H. Funato, M. Yoshimura, T. Yamazaki, T.C. Saido, Y. Ito, J. Yokofujita, R. Okeda, and Y. Ihara Astrocytes containing amyloid β-protein (Aβ)-positive granules are associated with Aβ40-positive diffuse plaques in the aged human brain Am. J. Pathol. 152 1998 983 992
62. D. Gabzuda, J. Busciglio, and B.A. Yanker Inhibition of β-Amyloid production by activation J. Neurochem. 61 1993 2326 2329
63. R. Galici, N.G. Echemendia, A.L. Rodriguez, and P.J. Conn A selective allosteric potentiator of metabotropic glutamate (mGlu) 2 receptors has effects similar to an orthosteric mGlu2/3 receptor agonist in mouse models predictive of antipsychotic activity J. Pharmacol. Exp. Ther. 315 2005 1181 1187
64. V. García-Marín, P. García-López, and M. Freire Cajal's contributions to glial research Trends Neurosci. 30 2007 479 487
65. L.M. García-Segura, and M.M. McCarthy Role of glia in neuroendocrine function Endocrinology 145 2004 1082 1086
66. J.J.G. Geurts, G. Wolswijk, L. Bö, P. van der Valk, C.H. Polman, D. Troost, and E. Aronica Altered expression patterns of group I and II metabotropic glutamate receptors in multiple sclerosis Brain 126 2003 1755 1766
67. S. Ghose, K.A. Gleason, B.W. Potts, K. Lewis-Amezcua, and C.A. Tamminga Differential expression of metabotropic glutamate receptors 2 and 3 in schizophrenia: a mechanism for antipsychotic drug action? Am. J. Psychiatry 166 2009 812 820
68. J. González-Maeso, R.L. Ang, T. Yuen, P. Chan, N.V. Weisstaub, J.F. López-Giménez, M. Zhou, Y. Okawa, L.F. Callado, G. Milligan, J.A. Gingrich, M. Filizola, J.J. Meana, and S.C. Sealfon Identification of a serotonin/glutamate receptor complex implicated in psychosis Nature 452 2008 93 97
69. J. Grosche, H. Kettenmann, and A. Reichenbach Bergmann glial cells form distinct morphological structures to interact with cerebellar neurons J. Neurosci. Res. 68 2002 138 149
70. J. Grosche, V. Matyash, T. Moller, A. Verkhratsky, A. Reichenbach, and H. Kettenmann Microdomains for neuron-glia interaction: parallel fiber signaling to Bergmann glial cells Nat. Neurosci. 2 1999 139 143
71. E. Gunnarson, M. Zelenina, and A. Aperia Regulation of brain aquaporins Neuroscience 129 2004 947 955
72. Y. Hayashi, M. Nomura, S. Yamagishi, S. Harada, J. Yamashita, and H. Yamamoto Induction of various blood-brain barrier properties in non-neural endothelial cells by close apposition to co-cultured astrocytes Glia 19 1997 13 26
73. G.A. Higgins, T.M. Ballard, J.N. Kew, J.G. Richards, J.A. Kemp, G. Adam, T. Woltering, S. Nakanishi, and V. Mutel Pharmacological manipulation of mGlu2 receptors influences cognitive performance in the rodent Neuropharmacology 46 2004 907 917
74. D.E. Jane, N.K. Thomas, H.-W. Tse, and J.C. Watkins Potent antagonists at the L-AP4- and (1S,3S)-ACPD sensitive presynaptic metabotropic glutamate receptors in the neonatal rat spinal cord Neuropharmacology 35 1996 1029 1035
75. R.C. Janzer, and M.C. Raff Astrocytes induce blood-brain barrier properties in endothelial cells Nature 325 1987 253 257
76. 2-receptors in prefrontal cortex and hippocampus J. Neurochem. 53 1989 1772 1781
77. M. Katsuno, H. Adachi, H. Banno, K. Suzuki, F. Tanaka, and G. Sobue Transforming growth factor-β signaling in motor neuron diseases Curr. Mol. Med. 11 2011 48 56
78. A.E. Kingston, M.J. O'Neill, A. Lam, K.R. Bales, J.A. Monn, and D.D. Schoepp Neuroprotection by metabotropic glutamate receptor agonists: LY354740, LY379268 and LY389795 Eur. J. Pharmacol. 377 1999 155 165
79. A. Klodzinska, M. Bijak, E. Chojnacka-Wojcik, B. Kroczka, M. Swiader, S.J. Czuczwar, and A. Pilc Roles of group II metabotropic glutamate receptors in modulating seizure activity Naunyn. Schmiedebergs Arch. Pharmacol. 361 2000 283 288
80. K. Kobayashi, M. Hayashi, H. Nakano, Y. Fukutani, K. Sasaki, M. Shimizaki, and Y. Koshino Apoptosis of astrocytes with enhanced lysosomal activity and oligodendrocytes in white matter lesions in Alzheimer's disease Neuropathol. Appl. Neurobiol. 28 2002 238 251
81. K. Krieglstein, F. Zheng, K. Unsicker, and C. Alzheimer More than being protective: functional roles for TGF-β/activin signaling pathways at central synapses Trends Neurosci. 34 2011 421 429
82. M. Lavialle, G. Aumann, E. Anlauf, F. Pröls, M. Arpin, and A. Derouiche Structural plasticity of perisynaptic astrocytes processes involves ezrin and metabotropic glutamate receptors Proc. Natl. Acad. Sci. U.S.A. 108 2011 12915 12919
83. P.M. Lea 4th, B. Wroblewska, J.M. Sarvey, and J.H. Neale Beta-NAAG rescues LTP from blockade by NAAG in rat dentate gyrus via the type 3 metabotropic glutamate receptor J. Neurophysiol. 85 2001 1097 1106
84. R.K.K. Lee, and R.J. Wurtman Metabotropic glutamate receptors increase amyloid precursor protein processing in astrocytes: inhibition by cyclic AMP J. Neurochem. 68 1997 1830 1835
85. K.P. Lehre, L.M. Levy, O.P. Ottersen, J. Storm-Mathisen, and N.C. Danbolt Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations J. Neurosci. 15 1995 1835 1853
86. 2 challenge in patients diagnosed with panic disorder Neuropharmacology 43 2002 294 295
87. C.M. Liberto, P.J. Albrecht, L.M. Herx, V.W. Yong, and S.W. Levison Pro-regenerative properties of cytokine-Activated astrocytes J. Neurochem. 89 2004 1092 1100
88. X.B. Liu, A. Munoz, and E.G. Jones Changes in subcellular localization of metabotropic glutamate receptor subtypes during postnatal development of mouse thalamus J. Comp. Neurol. 395 1998 450 465
89. K. Luyt, A. Váradi, C.F. Durant, and E. Molnár Oligodendroglial metabotropic glutamate receptors are developmentally regulated and involved in the prevention of apoptosis J. Neurochem. 99 2006 641 656
90. L. Lyon, J.N. Kew, C. Corti, P.J. Harrison, and P.W. Burnet Altered hippocampal expression of glutamate receptors and transporters in GRM2 and GRM3 knockout mice Synapse 62 2008 842 850
91. P.J. Magistretti, L. Pellerin, D.L. Rothman, and R.G. Shulman Energy on demand Science 283 1999 496 497
92. G.J. Marek Metabotropic glutamate 2/3 receptors as drug targets Curr. Opin. Pharmacol. 4 2004 18 22
93. G.J. Marek Glutamatergic mechanisms in antidepressant treatments Eur. Neuropsychopharmacol. 12 2002 S170 S171
94. J.A. Martin, D.K. Craft, J.H. Su, R.C. Kim, and C.W. Cotman Astrocytes degenerate in frontotemporal dementia: possible relation to hypoperfusion Neurobiol. Aging 22 2000 195 207
95. M. Martinez, E. Fernandez, A. Frank, C. Guaza, M. de la Fuente, and A. Hernanz Increased cerebrospinal fliud cAMP levels in Alzheimer's disease Brain Res. 846 1999 265 267
96. P. Marz, K. Heese, B. Dimitriades-Schmutz, S. Rose-John, and U. Otten Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression Glia 26 1999 191 200
97. P. Micevych, J. Kuo, and A. Christensen Physiology of membrane oestrogen receptor signaling in reproduction J. Neuroendocrinol. 21 2009 249 256
98. S. Miller, C. Romano, and C.W. Cotman Growth factor upregulation of a phosphoinositide-coupled metabotropic glutamate receptor in cortical astrocytes J. Neurosci. 15 1995 6103 6109
99. E. Mineff, and J. Valtschanoff Metabotropic glutamate receptors 2 and 3 expressed by astrocytes in rat ventrobasal thalamus Neurosci. Lett. 270 1999 95 98
100. T. Minoshima, and S. Nakanishi Structural organization of the mouse metabotropic glutamate receptor subtype 3 gene and its regulation by growth factors in cultured cortical astrocytes J. Biochem. 126 1999 889 896
101. R.X. Moldrich, K. Apricó, S. Diwakarla, R.D. O'Shea, and P.M. Beart Astrocyte mGlu(2/3)-mediated cAMP potentiation is calcium sensitive: studies in murine neuronal and astrocyte cultures Neuropharmacology 43 2002 189 203
102. R.X. Moldrich, M. Jeffrey, A. Talebi, P.M. Beart, A.G. Chapman, and B.S. Meldrum Antiepileptic activity of group II metabotropic glutamate receptor agonists (-)-2-oxa-4-Aminobicyclo[3.1.0]hexane-4,6-dicarboxylate (LY379268) and (-)-2-thia-4-Aminobicyclo[3.1.0]-hexane-4,6-dicarboxylate (LY389795) Neuropharmacology 41 2001 8 18
103. J.A. Monn, M.J. Valli, S.M. Massey, M.M. Hansen, T.J. Kress, J.P. Wepsiec, A.R. Harkness, J.L. Grutsch Jr.; R.A. Wright, B.G. Johnson, S.L. Andis, A. Kingston, R. Tomlinson, R. Lewis, K.R. Griffey, J.P. Tizzano, and D.D. Schoepp Synthesis, pharmacological characterization, and molecular modeling of heterobicyclic amino acids related to (+)-2-Aminobicyclo[3.1.0]hexane-2,6- dicarboxylic acid (LY354740): identification of two new potent, selective, and systemically active agonists for group II metabotropic glutamate receptors J. Med. Chem. 42 1999 1027 1040
104. J.A. Monn, M.J. Valli, S.M. Massey, R.A. Wright, C.R. Salhoff, B.G. Johnson, T. Howe, C.A. Alt, G.A. Rhodes, R.L. Robey, K.R. Griffey, J.P. Tizzano, M.J. Kallman, D.R. Helton, and D.D. Schoepp Design, synthesis, and pharmacological characterization of (+)-2-Aminobicyclo[3.1.0]hexane-2,6- dicarboxylic acid (LY354740): a potent, selective, and orally active group 2 metabotropic glutamate receptor agonist possessing anticonvulsant and anxiolytic properties J. Med. Chem. 40 1997 528 537
105. J.L. Moreno, S.C. Sealfon, and J. González-Maeso Group II metabotropic glutamate receptors and schizophrenia Cell Mol. Life Sci. 66 2009 3777 3785
106. G. Mudo, A. Trovato-Salinaro, G. Caniglia, Q. Cheng, and D.F. Condorelli Cellular localization of mGluR3 and mGluR5 mRNAs in normal and injured rat brain Brain Res. 1149 2007 1 13
107. H. Muller, U. Junghans, and J. Kappler Astroglial neurotrophic and neurite-promoting factors Pharmacol. Ther. 65 1995 1 18
108. T.K. Murray, M.J. Messenger, M.A. Ward, S. Woodhouse, D.J. Osborne, S. Duty, and M.J. O'Neill Evaluation of the mGlu2/3 agonist LY379268 in rodent models of Parkinson's disease Pharmacol. Biochem. Behav. 73 2002 455 466
109. R.G. Nagele, M.R. D'Andrea, H. Lee, V. Venkataraman, and H.Y. Wang Astrocytes accumulate Abeta 42 and give rise to astrocytic amyloid plaques in Alzheimer disease brains Brain Res. 971 2003 197 209
110. K. Nakahara, M. Okada, and S. Nakanishi The metabotropic glutamate receptor mGluR5 induces calcium oscillations in cultured astrocytes via protein kinase C phosphorylation J. Neurochem. 69 1997 1467 1475
111. J.H. Neale N-Acetylaspartylglutamate is an agonist at mGluR3 in vivo and in vitro J. Neurochem. 119 2011 891 895
112. D. Nguyen, M.V. Alavi, K.Y. Kim, T. Kang, R.T. Scott, Y.H. Noh, J.D. Lindsey, B. Wissinger, M.H. Ellisman, R.N. Weinreb, G.A. Perkins, and W.K. Ju A new vicious cycle involving glutamate excitotoxicity, oxidative stress and mitochondrial dynamics Cell Death Dis. 2 2011 e240 10.1038/cddis.2011.117
113. J.A.R. Nicoll, and R.O. Weller A new role for astrocytes: β-Amyloid homeostasis and degradation Trends Mol. Med. 9 2003 281 282
114. H. Ohishi, A. Neki, and N. Mizuno Distribution of a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat and mouse: an immunohistochemical study with a monoclonal antibody Neurosci. Res. 30 1998 65 82
115. H. Ohishi, R. Shigemoto, S. Nakanishi, and N. Mizuno Distribution of the messenger RNA for a metabotropic glutamate receptor, mGluR2, in the central nervous system of the rat Neuroscience 53 1993 1009 1018
116. H. Ohishi, R. Shigemoto, S. Nakanishi, and N. Mizuno Distribution of the mRNA for a metabotropic glutamate receptor (mGluR3) in the rat brain: an in situ hybridization study J. Comp. Neurol. 335 1993 252 266
117. R.T. Olszewski, M.M. Wegorzewska, A.C. Monteiro, K.A. Krolikowski, J. Zhou, A.P. Kozikowski, K. Long, J. Mastropaolo, S.I. Deutsch, and J.H. Neale Phencyclidine and dizocilpine induced behaviors reduced by N- Acetylaspartylglutamate peptidase inhibition via metabotropic glutamate receptors Biol. Psychiatry 63 2008 86 91
118. E. Palmer, D.T. Monaghan, and C.W. Cotman Trans-ACPD, a selective agonist of the phosphoinositide-coupled excitatory amino acid receptor Eur. J. Pharmacol. 166 1989 585 587
119. V. Parpura, and P.G. Haydon Physiological astrocytic calcium levels stimulate glutamate release to modulate adjacent neurons Proc. Natl. Acad. Sci. U.S.A. 97 2000 8629 8634
120. O. Pascual, K.B. Casper, C. Kubera, J. Zhang, R. Revilla-Sanchez, J.Y. Sul, H. Takano, S.J. Moss, K. McCarthy, and P.G. Haydon Astrocytic purinergic signaling coordinates synaptic networks Science 310 2005 113 116
121. S.T. Patil, L. Zhang, F. Martenyi, S.L. Lowe, K.A. Jackson, B.V. Andreev, A.S. Avedisova, L.M. Bardenstein, I.Y. Gurovich, M.A. Morozova, S.N. Mosolov, N.G. Neznanov, A.M. Reznik, A.B. Smulevich, V.A. Tochilov, B.G. Johnson, J.A. Monn, and D.D. Schoepp Activation of mGlu2/3 receptors as a new approach to treat schizophrenia: a randomized Phase 2 clinical trial Nat. Med. 13 2007 1102 1107
122. J. Peters, and P.W. Kalivas The group II metabotropic glutamate receptor agonist, LY379268, inhibits both cocaine- and food-seeking behavior in rats Psychopharmacology 186 2006 143 149
123. R.S. Petralia, Y.X. Wang, A.S. Niedzielsk, and R.J. Wenthold The metabotropic glutamate receptors, mGluR2 and mGluR3, show unique postsynaptic, presynaptic and glial localizations Neuroscience 71 1996 949 976
124. F.W. Pfrieger, and B.A. Barres Synaptic efficacy enhanced by glial cells in vitro Science 227 1997 1684 1687
125. J.-P. Pin, and F. Acher The metabotropic glutamate receptors: structure, activation mechanism and pharmacology Curr. Drug Targets CNS Neurol. Disord. 1 2002 297 317
126. A. Poli, A. Beraudi, L. Villani, M. Storto, G. Battaglia, V. Di Giorgi Gerevini, I. Cappuccio, A. Caricasole, M. D'Onofrio, and F. Nicoletti Group II metabotropic glutamate receptors regulate the vulnerability to hypoxic brain damage J. Neurosci. 23 2003 6023 6029
127. B. Pöschel, B. Wroblewska, U. Heinemann, and D. Manahan-Vaughan The metabotropic glutamate receptor mGluR3 is critically required for hippocampal long-term depression and modulates long-term potentiation in the dentate gyrus of freely moving rats Cereb. Cortex 15 2005 1414 1423
128. D.V. Pow Visualising the activity of the cystine-glutamate antiporter in glial cells using antibodies to aminoadipic acid, a selectively transported substrate Glia 34 2001 27 38
129. G. Riedel, B. Platt, and J. Micheau Glutamate receptor function in learning and memory Behav. Brain Res. 140 2003 1 47
130. J.J. Rodríguez, M. Olabarría, A. Chvatal, and A. Verkhratsky Astroglia in dementia and Alzheimer's disease Cell Death Differ. 16 2009 378 385
131. L.M. Rorick-Kehn, B.G. Johnson, J.L. Burkey, R.A. Wright, D.O. Calligaro, G.J. Marek, E.S. Nisenbaum, J.T. Catlow, A.E. Kingston, D.D. Giera, M.F. Herin, J.A. Monn, D.L. McKinzie, and D.D. Schoepp Pharmacological and pharmacokinetic properties of structurally novel, potent, and selective metabotropic glutamate 2/3 receptor agonist: in vitro characterization of agonist (-)-(1R,4S,5S,6S)-4- Amino-2-sulfonylbicyclo[3.1.0]-hexane-4,6-dicarboxylic acid (LY404039) J. Pharmacol. Exp. Ther. 321 2007 308 317
132. J.S. Rudge, E.M. Pasnikowski, P. Holst, and R.M. Lindsay Changes in neurotrophic factor expression and receptor activation following exposure of hippocampal neuron/astrocyte cocultures to kainic acid J. Neurosci. 15 1995 6856 6867
133. +2-dependent glutamate release Neuroscience 158 2009 253 259
134. L.J. Sartorius, D.R. Weinberger, T.M. Hyde, P.J. Harrison, J.E. Kleinman, and B.K. Lipska Expression of a GRM3 splice variant is increased in the dorsolateral prefrontal cortex of individuals carrying a schizophrenia risk SNP Neuropsychopharmacology 33 2008 2626 2634
135. + -dependent glutamate transporters by cyclic AMP analogs and neurons Mol. Pharmacol. 53 1998 355 369
136. D.D. Schoepp Unveiling the functions of presynatic metabotropic glutamate receptor in the central nervous system J. Pharmacol. Exp. Ther. 299 2001 12 20
137. D.D. Schoepp, R.A. Wright, L.R. Levine, B. Gaydos, and W.Z. Potter LY354740, an mGlu2/3 receptor agonist as a novel approach to treat anxiety/stress Stress 6 2003 189 197
138. G.P. Schools, and H.K. Kimelberg mGluR3 and mGluR5 are the predominant metabotropic glutamate receptor mRNAs expressed in hippocampal astrocytes acutely isolated from young rats J. Neurosci. Res. 58 1999 533 543
139. P. Schubert, T. Ogata, S. Ferroni, A. McRae, Y. Nakamura, and K. Rudolphi Modulation of glial cell signaling by adenosine and pharmacological reinforcement Mol. Chem. Neuropathol. 28 1996 185 190
140. J.P. Schwartz, and N. Nishiyama Neurotrophic factor gene expression in astrocytes during development and following injury Brain Res. Bull. 35 1994 403 407
141. L.M. Shaffer, M.D. Dority, R. Gupta-Bansal, R.C. Frederickson, S.G. Younkin, and K.R. Brunden Amyloid β protein (Aβ) removal by neuroglial cells in culture Neurobiol. Aging 16 1995 737 745
142. R. Shigemoto, A. Kinoshita, E. Wada, S. Nomura, H. Ohishi, M. Takada, P.J. Flor, A. Neki, T. Abe, S. Nakanishi, and N. Mizuno Differential presynaptic localization of metabotropic glutamate receptor subtypes in the rat hippocampus J. Neurosci. 17 1997 7503 7522
143. R.M.A. Simmons, A.A. Webster, A. Kalra, and S. Iyengar Group II mGlu receptor agonists are effective in persistent and neuropathic pain models in rats Pharmacol. Biochem. Behav. 73 2002 419 427
144. K. Sobue, N. Yamamoto, K. Yoneda, M.E. Hodgson, K. Yamashiro, N. Tsuruoka, T. Tsuda, H. Katsuya, Y. Miura, K. Asai, and T. Kato Induction of blood-brain barrier properties in immortalized bovine brain endothelial cells by astrocytic factors Neurosci. Res. 35 1999 155 164
145. I. Suarez, G. Bodega, and B. Fernandez Glutamine synthetase in brain: effect of ammonia Neurochem. Int. 41 2002 123 142
146. K.R. Swartz, F. Liu, D. Sewell, T. Schochet, I. Campbell, M. Sandor, and Z. Fabry Interleukin-6 promotes post-traumatic healing in the central nervous system Brain Res. 896 2001 86 95
147. T. Takano, G.F. Tian, W. Peng, N. Lou, W. Libionka, X. Han, and M. Nedergaard Astrocyte-mediated control of cerebral blood flow Nat. Neurosci. 9 2006 260 267
148. K. Takuma, A. Baba, and T. Matsuda Astrocyte apoptosis: implications for neuroprotection Prog. Neurobiol. 72 2004 111 127
149. Y. Tamaru, S. Nomura, N. Mizuno, and R. Shigemoto Distribution of metabotropic glutamate receptor mGluR3 in the mouse CNS: differential location to pre- and postsynaptic sites Neuroscience 106 2001 481 503
150. X.C. Tang, and P.W. Kalivas Bidirectional modulation of cystine/glutamate exchanger activity in cultured cortical astrocytes Ann. NY Acad. Sci. 1003 2003 472 475
151. D.L. Taylor, L.T. Diemel, M.L. Cuzner, and J.M. Pocock Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up-regulated
152. I. Tesseur, K. Zou, L. Esposito, F. Bard, E. Berber, J.V. Can, A.H. Lin, L. Crews, P. Tremblay, P. Mathews, L. Mucke, E. Masliah, and T. Wyss-Coray Deficiency in neuronal TGF-beta signaling promotes neurodegeneration and Alzheimer's pathology J. Clin. Invest. 116 2006 3060 3069
153. D.R. Thal, I. Sassin, C. Schultz, C. Haass, E. Braak, and H. Braak Fleecy amyloid deposits in the internal layers of the human entorhinal cortex are comprised of N-terminal truncated fragments of Aβ J. Neuropathol. Exp. Neurol. 58 1999 210 216
154. D.T. Theodosis, D.A. Poulain, and S.H. Oliet Activity-dependent structural and functional plasticity of astrocyte-neuron interactions Physiol. Rev. 88 2008 983 1008
155. G. Thinakaran, and E.H. Koo Amyloid precursor protein trafficking, processing, and function J. Biol. Chem. 283 2008 29615 29619
156. H. Tomimoto, I. Akiguchi, H. Wakita, T. Suenaga, S. Nakamura, and J. Kimura Regressive changes of astroglia in white matter lesions in cerebrovascular disease and Alzheimer's disease patients Acta Neuropathol. 94 1997 146 152
157. E.M. Ullian, S.K. Sapperstein, K.S. Christopherson, and B.A. Barres Control of synapse number by glia Science 291 2001 657 661
158. I.H. Ulus, and R.J. Wurtman Metabotropic glutamate receptor agonists increase release of soluble amyloid precursor protein derivatives from rat brain cortical and hippocampal slices J. Pharmacol. Exp. Ther. 281 1997 149 154
159. R. Ventura, and K.M. Harris Three-dimensional relationships between hippocampal synapses and astrocytes J. Neurosci. 19 1999 6897 6906
160. H.S. Walton, and P.R. Dodd Glutamate-glutamine cycling in Alzheimer's disease Neurochem. Int. 50 2007 1052 1066
161. J. Wilson Antioxidant defense of the brain: a role for astrocytes Can. J. Physiol. Pharmacol. 75 1997 1149 1163
162. B. Wroblewska, S. Pshenichkin, E.J. Miller, J. DiRaddo, E. Grajkowska, and J.T. Wroblewski Selective agonists of mGlu3 receptors: N- Acetylaspartylglutamate (NAAG) and 2-Hydroxymethylglutamate (HMG) Curr. Neuropharmacol. 9 Suppl. 1 2011 67 68
163. B. Wroblewska, I. Wegorzewska, T. Bzdega, R. Olszewski, and J. Neal Differential negative coupling of type 3 metabotropic glutamate receptor to cyclic GMP levels in neurons and astrocytes J. Neurochem. 96 2006 1071 1077
164. T. Wyss-Coray, J.D. Loike, T.C. Brionne, E. Lu, R. Anankov, F. Yan, S.C. Silverstein, and J. Husemann Adult mouse astrocytes degrade amyloid-β in vitro and in situ Nat. Med. 9 2003 453 457
165. H.-H. Yao, J.-H. Ding, F. Zhou, F. Wang, L.F. Hu, T. Sun, and G. Hu Enhancement of glutamate uptake mediates the neuroprotection exerted by activating group II or III metabotropic glutamate receptors on astrocytes J. Neurochem. 92 2005 948 961
166. C. Zhong, X. Zhao, J. Sarva, A. Kozikowski, J.H. Neale, and B.G. Lyeth NAAG peptidase inhibitor reduces acute neuronal degeneration and astrocyte damage following lateral fluid percussion TBI in rats J. Neurotrauma 22 2005 266 276
167. F. Zhou, H. Yao, J. Wu, Y. Yang, J. Ding, J. Zhang, and G. Hu Activation of group II/III metabotropic glutamate receptors attenuates LPS-induced astroglial neurotoxicity via promoting glutamate uptake J. Neurosci. Res. 84 2006 268 277